Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Acute hyperinsulinemia effects on systemic markers of immune activation in HIV.

O'malley TK, Burdo TH, Robinson JA, Fitch KV, Grinspoon SK, Srinivasa S.

AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001545. [Epub ahead of print]

PMID:
28514281
2.

Follow YOUR Heart: development of an evidence-based campaign empowering older women with HIV to participate in a large-scale cardiovascular disease prevention trial.

Zanni MV, Fitch K, Rivard C, Sanchez L, Douglas PS, Grinspoon S, Smeaton L, Currier JS, Looby SE.

HIV Clin Trials. 2017 Mar;18(2):83-91. doi: 10.1080/15284336.2017.1297551.

PMID:
28277924
3.

Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in HIV.

Toribio M, Fitch KV, Sanchez L, Burdo TH, Williams KC, Sponseller CA, McCurdy Pate M, Aberg JA, Zanni MV, Grinspoon SK.

AIDS. 2017 Mar 27;31(6):797-806. doi: 10.1097/QAD.0000000000001427.

PMID:
28252528
4.

Biomarkers and Clinical Indices of Aging with HIV.

Fitch KV, Feldpausch MN, Looby SE.

Interdiscip Top Gerontol Geriatr. 2017;42:47-58. Epub 2016 Nov 22.

PMID:
27875823
5.

Effects of Sodium Restriction on Activation of the Renin-Angiotensin-Aldosterone System and Immune Indices During HIV Infection.

Srinivasa S, Burdo TH, Williams KC, Mitten EK, Wong K, Fitch KV, Stanley T, Adler GK, Grinspoon SK.

J Infect Dis. 2016 Nov 1;214(9):1336-1340. Epub 2016 Aug 22.

PMID:
27549584
6.

Subclinical myocyte injury, fibrosis and strain in relationship to coronary plaque in asymptomatic HIV-infected individuals.

Fitch KV, DeFilippi C, Christenson R, Srinivasa S, Lee H, Lo J, Lu MT, Wong K, Petrow E, Sanchez L, Looby SE, Hoffmann U, Zanni M, Grinspoon SK.

AIDS. 2016 Sep 10;30(14):2205-14. doi: 10.1097/QAD.0000000000001186.

PMID:
27314177
7.

A multiplexed targeted assay for high-throughput quantitative analysis of serum methylamines by ultra performance liquid chromatography coupled to high resolution mass spectrometry.

Kadar H, Dubus J, Dutot J, Hedjazi L, Srinivasa S, Fitch KV, Grinspoon SK, Nicholson JK, Dumas ME, Gauguier D.

Arch Biochem Biophys. 2016 May 1;597:12-20. doi: 10.1016/j.abb.2016.03.029. Epub 2016 Mar 30.

PMID:
27036856
8.

Dysfunctional Subcutaneous Fat With Reduced Dicer and Brown Adipose Tissue Gene Expression in HIV-Infected Patients.

Torriani M, Srinivasa S, Fitch KV, Thomou T, Wong K, Petrow E, Kahn CR, Cypess AM, Grinspoon SK.

J Clin Endocrinol Metab. 2016 Mar;101(3):1225-34. doi: 10.1210/jc.2015-3993. Epub 2016 Jan 12.

9.

HIV-Related Cardiovascular Disease, Statins, and the REPRIEVE Trial.

Gilbert JM, Fitch KV, Grinspoon SK.

Top Antivir Med. 2015 Oct-Nov;23(4):146-9.

10.

Reduced ovarian reserve relates to monocyte activation and subclinical coronary atherosclerotic plaque in women with HIV.

Looby SE, Fitch KV, Srinivasa S, Lo J, Rafferty D, Martin A, Currier JC, Grinspoon S, Zanni MV.

AIDS. 2016 Jan 28;30(3):383-93. doi: 10.1097/QAD.0000000000000902.

11.

Serum oxidized low-density lipoprotein decreases in response to statin therapy and relates independently to reductions in coronary plaque in patients with HIV.

Nou E, Lu MT, Looby SE, Fitch KV, Kim EA, Lee H, Hoffmann U, Grinspoon SK, Lo J.

AIDS. 2016 Feb 20;30(4):583-90. doi: 10.1097/QAD.0000000000000946.

12.

Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial.

Lo J, Lu MT, Ihenachor EJ, Wei J, Looby SE, Fitch KV, Oh J, Zimmerman CO, Hwang J, Abbara S, Plutzky J, Robbins G, Tawakol A, Hoffmann U, Grinspoon SK.

Lancet HIV. 2015 Feb;2(2):e52-63. doi: 10.1016/S2352-3018(14)00032-0. Epub 2015 Jan 9.

13.

RAAS Activation Is Associated With Visceral Adiposity and Insulin Resistance Among HIV-infected Patients.

Srinivasa S, Fitch KV, Wong K, Torriani M, Mayhew C, Stanley T, Lo J, Adler GK, Grinspoon SK.

J Clin Endocrinol Metab. 2015 Aug;100(8):2873-82. doi: 10.1210/jc.2015-1461. Epub 2015 Jun 18.

14.

Plaque burden in HIV-infected patients is associated with serum intestinal microbiota-generated trimethylamine.

Srinivasa S, Fitch KV, Lo J, Kadar H, Knight R, Wong K, Abbara S, Gauguier D, Capeau J, Boccara F, Grinspoon SK.

AIDS. 2015 Feb 20;29(4):443-52. doi: 10.1097/QAD.0000000000000565.

15.

2013 American College of Cardiology/American Heart Association and 2004 Adult Treatment Panel III cholesterol guidelines applied to HIV-infected patients with/without subclinical high-risk coronary plaque.

Zanni MV, Fitch KV, Feldpausch M, Han A, Lee H, Lu MT, Abbara S, Ribaudo H, Douglas PS, Hoffmann U, Lo J, Grinspoon SK.

AIDS. 2014 Sep 10;28(14):2061-70. doi: 10.1097/QAD.0000000000000360.

16.

Soluble CD163 is associated with shortened telomere length in HIV-infected patients.

Srinivasa S, Fitch KV, Petrow E, Burdo TH, Williams KC, Lo J, Côté HC, Grinspoon SK.

J Acquir Immune Defic Syndr. 2014 Dec 1;67(4):414-8. doi: 10.1097/QAI.0000000000000329.

17.

Effects of lifestyle modification and metformin on irisin and FGF21 among HIV-infected subjects with the metabolic syndrome.

Srinivasa S, Wong K, Fitch KV, Wei J, Petrow E, Cypess AM, Torriani M, Grinspoon SK.

Clin Endocrinol (Oxf). 2015 May;82(5):678-85. doi: 10.1111/cen.12582. Epub 2014 Oct 8.

18.

Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women.

Fitch KV, Srinivasa S, Abbara S, Burdo TH, Williams KC, Eneh P, Lo J, Grinspoon SK.

J Infect Dis. 2013 Dec 1;208(11):1737-46. doi: 10.1093/infdis/jit508. Epub 2013 Sep 16.

19.

Increased FDG uptake in association with reduced extremity fat in HIV patients.

Torriani M, Zanni MV, Fitch K, Stavrou E, Bredella MA, Lim R, Cypess AM, Grinspoon S.

Antivir Ther. 2013;18(2):243-8. doi: 10.3851/IMP2420. Epub 2012 Oct 5.

20.

Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers.

Pereyra F, Lo J, Triant VA, Wei J, Buzon MJ, Fitch KV, Hwang J, Campbell JH, Burdo TH, Williams KC, Abbara S, Grinspoon SK.

AIDS. 2012 Nov 28;26(18):2409-12. doi: 10.1097/QAD.0b013e32835a9950.

Supplemental Content

Loading ...
Support Center